A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
Condition(s):HPV-Related Cervical Carcinoma; HPV Positive Oropharyngeal Squamous Cell CarcinomaLast Updated:March 20, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):HPV-Related Cervical Carcinoma; HPV Positive Oropharyngeal Squamous Cell CarcinomaLast Updated:March 20, 2024Not yet recruiting
Condition(s):Immunization; VaccinationLast Updated:January 12, 2022Unknown status
Condition(s):Immunization; VaccinationLast Updated:April 30, 2020Completed
Condition(s):Human Papillomavirus InfectionLast Updated:January 4, 2023Active, not recruiting
Condition(s):Cervical CancerLast Updated:August 6, 2018Unknown status
Condition(s):Human Papilloma Virus; HIV InfectionsLast Updated:February 23, 2024Completed
Condition(s):HPV; Immunization; Human Papilloma VirusLast Updated:August 29, 2023Completed
Condition(s):Human PapillomavirusLast Updated:February 12, 2024Completed
Condition(s):Human Papilloma Virus; Cervical Intraepithelial Neoplasia; Cervical CancerLast Updated:October 6, 2023Recruiting
Condition(s):Immunization; VaccinationLast Updated:July 5, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.